Investing Ideas
/
Swedish Pharmaceuticals & Biotech Price disconnect

Swedish Pharmaceuticals & Biotech Price disconnect

Results

0 new

Stocks which the market has priced substantially different to their cash flows, which could imply risk.

4 companies

Bonesupport Holding

Market Cap: SEK 14.6b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

BONEX

SEK 219.20

-0.5%

-30.6%

Swedencare

Market Cap: SEK 3.5b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

SECARE

SEK 21.85

-1.1%

-40.9%

Cantargia

Market Cap: SEK 446.3m

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

CANTA

SEK 1.83

1.0%

-40.6%

Sprint Bioscience

Market Cap: SEK 367.2m

A pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden.

SPRINT

SEK 3.42

-8.3%

497.9%